Bird flu has had a nationwide effect causing harm to the poultry and domestic animals but it also has been posing a risk to human health. While the health risk is low, people have been cautioned.
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
The nationwide spread of highly pathogenic avian influenza, HPAI, also known as avian or bird flu, has many in Illinois ...
The mRNA vaccine against avian influenza presents several advantages and disadvantages: Advantages: Rapid Development and Production; Non-Infectious Nature; Strong Immune Response; Adaptability to ...
The Pennsylvania Department of Agriculture confirmed the first positive case of Highly Pathogenic Avian Influenza (HPAI) in domestic poultry in Pennsylvania on Monday January 27, in a 50,000-bird laye ...
A new strain of bird flu, H5N9, has been detected for the first time in the United States, raising concerns about how it ...